Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics

[1]  K. Clément,et al.  A distinct adipose tissue gene expression response to caloric restriction predicts 6-mo weight maintenance in obese subjects. , 2011, The American journal of clinical nutrition.

[2]  J. Schwarz,et al.  Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. , 2003, The American journal of clinical nutrition.

[3]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[4]  B. Kahan,et al.  Adjusting for multiple prognostic factors in the analysis of randomised trials , 2013, BMC Medical Research Methodology.

[5]  T. Larsen,et al.  The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries – a comprehensive design for long‐term intervention , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[6]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[7]  A. Valsesia,et al.  Distinct lipid profiles predict improved glycemic control in obese, nondiabetic patients after a low-caloric diet intervention: the Diet, Obesity and Genes randomized trial. , 2016, The American journal of clinical nutrition.

[8]  W. James,et al.  Effect of Plain Versus Sugar‐Sweetened Breakfast on Energy Balance and Metabolic Health: A Randomized Crossover Trial , 2020, Obesity.

[9]  F. Ortego,et al.  Multiple mutations in the nicotinic acetylcholine receptor Ccα6 gene associated with resistance to spinosad in medfly , 2019, Scientific Reports.

[10]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[11]  Protein quantitative trait locus study in obesity during weight-loss identifies a leptin regulator , 2017, Nature Communications.

[12]  J. Halford,et al.  Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation , 2019, Scientific Reports.

[13]  K. Frayn.  Visceral fat and insulin resistance — causative or correlative? , 2000, British Journal of Nutrition.

[14]  Massimo Midiri,et al.  Visceral Adiposity Index , 2010, Diabetes Care.

[15]  A. Valsesia,et al.  Genome-wide gene-based analyses of weight loss interventions identify a potential role for NKX6.3 in metabolism , 2019, Nature Communications.

[16]  A. Vidal-Puig,et al.  It's Not How Fat You Are, It's What You Do with It That Counts , 2008, PLoS biology.

[17]  D. Reboussin,et al.  Patterns of Weight Change Associated With Long‐Term Weight Change and Cardiovascular Disease Risk Factors in the Look AHEAD Study , 2012, Obesity.

[18]  Gopal R. Gopinath,et al.  Reactome: a knowledge base of biologic pathways and processes , 2007, Genome Biology.

[19]  C. Drevon,et al.  APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome , 2017, Scientific Reports.

[20]  Gopal R. Gopinath,et al.  Correction: Reactome: a knowledge base of biologic pathways and processes , 2009, Genome Biology.

[21]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[22]  N. Plant,et al.  Fatty acid binding proteins: tissue-specific functions in health and disease , 2014, Current opinion in clinical nutrition and metabolic care.

[23]  L. Kritharides,et al.  Regulation of endogenous apolipoprotein E secretion by macrophages. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[24]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[25]  H. Ginsberg,et al.  Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. , 2005, Circulation research.

[26]  G. Getz,et al.  Extrahepatic synthesis of apolipoprotein E. , 1984, Journal of lipid research.

[27]  R. DeFronzo,et al.  Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[28]  A. Valsesia,et al.  Subcutaneous Adipose Tissue and Systemic Inflammation Are Associated With Peripheral but Not Hepatic Insulin Resistance in Humans , 2019, Diabetes.

[29]  A. Valsesia,et al.  Plasma metabolites and lipids predict insulin sensitivity improvement in obese, nondiabetic individuals after a 2-phase dietary intervention , 2018, The American journal of clinical nutrition.

[30]  Roy Taylor,et al.  Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial , 2017, The Lancet.

[31]  D. Mozaffarian,et al.  Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study. , 2011, The American journal of clinical nutrition.

[32]  Tae Woo Jung,et al.  Implication of hepatokines in metabolic disorders and cardiovascular diseases , 2016, BBA clinical.

[33]  G. Bray,et al.  Obesity , 2008, Annals of Internal Medicine.

[34]  M Kanehisa,et al.  Organizing and computing metabolic pathway data in terms of binary relations. , 1997, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[35]  J. Friedman.  Stochastic gradient boosting , 2002 .

[36]  R. DeFronzo,et al.  Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. , 2006, Diabetes care.

[37]  M. Rudemo,et al.  Identification of adipocyte genes regulated by caloric intake. , 2010, The Journal of clinical endocrinology and metabolism.

[38]  E. Weiss,et al.  Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk , 2014, Diabetes/metabolism research and reviews.

[39]  S. Klein,et al.  Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications , 2010, Hepatology.

[40]  A. Dobrzyń,et al.  Stearoyl-CoA desaturase and insulin signaling--what is the molecular switch? , 2010, Biochimica et biophysica acta.

[41]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[42]  Larry Gold,et al.  Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents , 2014, Molecular therapy. Nucleic acids.

[43]  J. Ntambi,et al.  Loss of Stearoyl-CoA Desaturase-1 Improves Insulin Sensitivity in Lean Mice but Worsens Diabetes in Leptin-Deficient Obese Mice , 2007, Diabetes.

[44]  P. Havel.  Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. , 2004, Diabetes.

[45]  A. Valsesia,et al.  Transcriptome profiling from adipose tissue during a low-calorie diet reveals predictors of weight and glycemic outcomes in obese, nondiabetic subjects. , 2017, The American journal of clinical nutrition.

[46]  M. Lean,et al.  Pathophysiology of obesity , 2000, Proceedings of the Nutrition Society.

[47]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[48]  Max Kuhn,et al.  Building Predictive Models in R Using the caret Package , 2008 .

[49]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[50]  A. Astrup,et al.  Diets with high or low protein content and glycemic index for weight-loss maintenance. , 2010, The New England journal of medicine.

[51]  Robert Tibshirani,et al.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.

[52]  J. Dixon,et al.  The effect of obesity on health outcomes , 2010, Molecular and Cellular Endocrinology.

[53]  M. Watt,et al.  Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance , 2017, Nature Reviews Endocrinology.

[54]  Amalia Gastaldelli,et al.  Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study , 2017, Diabetes.

[55]  Anushya Muruganujan,et al.  PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification , 2003, Nucleic Acids Res..

[56]  M. Kanzaki,et al.  Involvement of Apolipoprotein E in Excess Fat Accumulation and Insulin Resistance , 2007, Diabetes.

[57]  Age K Smilde,et al.  Weight loss predictability by plasma metabolic signatures in adults with obesity and morbid obesity of the DiOGenes study , 2016, Obesity.

[58]  Nathalie Villa-Vialaneix,et al.  Determinants of Human Adipose Tissue Gene Expression: Impact of Diet, Sex, Metabolic Status, and Cis Genetic Regulation , 2012, PLoS genetics.

[59]  P. MacLean,et al.  The role for adipose tissue in weight regain after weight loss , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[60]  Elisavet H. Fotiadou,et al.  Mechanisms of obesity and related pathologies: Role of apolipoprotein E in the development of obesity , 2009, The FEBS journal.

[61]  Eric R. Ziegel,et al.  The Elements of Statistical Learning , 2003, Technometrics.

[62]  R. Alfenas,et al.  Meal replacement based on Human Ration modulates metabolic risk factors during body weight loss: a randomized controlled trial , 2014, European Journal of Nutrition.

[63]  Shuiping Zhao,et al.  Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non‐alcoholic fatty liver disease , 2015, Biological reviews of the Cambridge Philosophical Society.

[64]  A. Astrup,et al.  Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi‐centre intervention study after a low‐energy diet in 2500 overweight, individuals with pre‐diabetes (PREVIEW) , 2018, Diabetes, obesity & metabolism.

[65]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, Nature Precedings.

[66]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .